Skip Navigation

Journal of Biochemistry 2004 136(6):831-837; doi:10.1093/jb/mvh193
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Koito, W.
Right arrow Articles by Nagai, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koito, W.
Right arrow Articles by Nagai, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 The Japanese Biochemical Society

BIOCHEMISTRY

Conventional Antibody against N{varepsilon}-(Carboxymethyl)Lysine (CML) Shows Cross-Reaction to N{varepsilon}-(Carboxyethyl)Lysine (CEL): Immunochemical Quantification of CML with a Specific Antibody

Wakako Koito1, Tomohiro Araki2, Seikoh Horiuchi1 and Ryoji Nagai1,*

1 Department of Medical Biochemistry, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Honjo 1-1-1, Kumamoto 860-8556; and 2 Faculty of Agriculture, Kyushu Tokai University, Kumamoto

Immunological strategies for the detection of N{varepsilon}-(carboxymethyl)lysine (CML), one of the major antigenic structures of advanced glycation end products (AGE), are widely applied to demonstrate the contribution of CML to the pathogeneses of diabetic complications and atherosclerosis. Recent studies have indicated that methylglyoxal (MG), which is generated intracellularly through the Embden-Meyerhof and polyol pathways, reacts with proteins to form MG-derived AGE structures such as N{varepsilon}-(carboxyethyl)lysine (CEL). In order to accurately measure the CML contents of the proteins by means of an immunochemical method, we prepared CML-specific antibodies since conventionally prepared polyclonal anti-CML antibody and monoclonal anti-CML antibody (6D12) cross-reacted with CEL. To prepare polyclonal CML-specific antibody, CML-keyhole limpet hemocyanin (CML-KLH) were immunized with rabbit and CEL-reactive antibody was removed by CEL-conjugated affinity chromatography. Monoclonal antibody specific for CML (CMS-10) was obtained by immunization with CML-KLH, followed by successive screening according to CML-bovine serum albumin (CML-BSA)–positive but CEL-BSA-negative criteria. Both polyclonal CML-specific antibody and CMS-10 significantly reacted with CML-proteins but not with CEL-proteins. It is likely therefore that these antibodies can recognize the difference of one methyl group between CML and CEL. Moreover, CMS-10 significantly reacted with BSA modified with several aldehydes and its reactivity was highly correlated with the CML content, which was determined by high performance liquid chromatography, whereas 6D12 showed a low correlation. These results indicate that CMS-10 can be used to determine the CML contents of modified proteins in a more specific way.

* To whom correspondence should be addressed. Phone: +81-96-373-5071, Fax: +81-96-364-6940, E-mail: nagai{at}kaiju.medic.kumamoto-u.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann. N. Y. Acad. Sci.Home page
R. NAGAI, Y. FUJIWARA, K. MERA, K. MOTOMURA, Y. IWAO, K. TSURUSHIMA, M. NAGAI, K. TAKEO, M. YOSHITOMI, M. OTAGIRI, et al.
Usefulness of Antibodies for Evaluating the Biological Significance of AGEs
Ann. N.Y. Acad. Sci., April 1, 2008; 1126(1): 38 - 41.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.